Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16Thoracic 4Head & Neck 4Gynecologic 3Genitourinary 3Dermatologic 3CNS 2Other solid neoplasm 1Breast 1

Conditions

Breast Neoplasms 40Triple Negative Breast Neoplasms 34Carcinoma, Non-Small-Cell Lung 28Melanoma 18Ovarian Neoplasms 16Carcinoma, Renal Cell 16Neoplasm Metastasis 13Pancreatic Neoplasms 12Carcinoma, Transitional Cell 12Colorectal Neoplasms 11Stomach Neoplasms 9Squamous Cell Carcinoma of Head and Neck 9Neoplasms 9Uterine Cervical Neoplasms 7Lung Neoplasms 7Head and Neck Neoplasms 7Endometrial Neoplasms 7Carcinoma, Merkel Cell 7Carcinoma, Hepatocellular 7Small Cell Lung Carcinoma 6Prostatic Neoplasms 6Gastrointestinal Neoplasms 5Sarcoma 4Mesothelioma 4Urinary Bladder Neoplasms 3Lymphoma 3Hodgkin Disease 3Esophageal Neoplasms 3Cholangiocarcinoma 3Carcinoma, Ovarian Epithelial 3

Interventions

pembrolizumab 5spartalizumab 2durvalumab 2Immunohistochemistry 2Gemcitabine 2130-nm albumin-bound paclitaxel 2tremelimumab 1obinutuzumab 1naptumomab estafenatox 1liposomal doxorubicin 1elgemtumab 1Polymerase Chain Reaction 1Oxaliplatin 1Nivolumab 1Mass Spectrometry 1Leucovorin 1LGK974 1Itraconazole 1In Situ Hybridization, Fluorescence 1Fulvestrant 1Fluorouracil 1EC regimen 1Cisplatin 1Carboplatin 1CP protocol 1Biopsy 1Bevacizumab 1Albumin-Bound Paclitaxel 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Nivolumab × Breast × Clear all
NCT04925284 2025-04-04

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Exelixis

Phase 1 Completed
269 enrolled
BreastGastrointestinalGynecologicThoracic

Carcinoma, Ovarian Epithelial, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Pancreatic Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡